MD1 and Mirla Avila Archives - 2021 CMSC Annual Meeting

2021 CMSC Annual Meeting

Tag: MD1 and Mirla Avila

Poster-Disease-modifying Therapy

October 25, 2021

The Benefits of Azathioprine in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Systematic Review and Meta-Analysis

Background: MOGAD is an emerging inflammatory demyelination disorder of the central nervous system. AZA is one of the commonly used...

Read More →

MAILING ADDRESS

3 University Plaza Drive, Ste 116
Hackensack, NJ 07601

CONTACT US

(201) 487-1050
info@mscare.org

FOLLOW US

© 2021 CMSC